Deep Serratus Anterior Plane Block vs Surgically-placed Paravertebral Block for VATS Surgery
SAPB
Comparison of Ultrasound-guided Continuous Serratus Anterior Plane Blockade With Continuous Thoracic Paravertebral Blockade for Perioperative Analgesia Following Video-assisted Thoracoscopic Surgery (VATS)
1 other identifier
interventional
40
1 country
1
Brief Summary
Thoracic surgery, and surgery involving the chest wall in general, is associated with poorly controlled acute pain, which may result in delayed functional recovery, and may progress to chronic pain. Multimodal opioid-sparing analgesia regimens are a key component of the thoracic surgery enhanced recovery pathway, the aim of which is to improve outcomes in patients undergoing both minimally invasive and open thoracic surgical procedures. Novel interfascial plane blocks are emerging as feasible alternatives to central neuraxial analgesia techniques in a variety of clinical settings. The aim of this study is to show non-inferiority of serratus anterior blockade compared with surgically placed paravertebral blocks in the management of perioperative acute pain in patients undergoing VATS procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
September 27, 2018
CompletedFirst Posted
Study publicly available on registry
December 7, 2018
CompletedDecember 7, 2018
December 1, 2018
11 months
September 27, 2018
December 5, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Opioid consumption
Expressed as oral morphine equivalent
Over the first 48 hours postoperatively
Secondary Outcomes (9)
Postoperative numerical pain scores
Over the first 48 hours postoperatively
Opioid side - effects - 1
Over the first 48 hours postoperatively
Opioid side - effects - 2
Over the first 48 hours postoperatively
Opioid side - effects - 3
Over the first 48 hours postoperatively
Mean arterial blood pressure
Over the first 48 hours postoperatively.
- +4 more secondary outcomes
Study Arms (2)
Deep serratus anterior plane block
EXPERIMENTALUltrasound-guided deposition of 40mls of 2mg/ kg levobupivacaine into the deep serratus anterior plane space, in the mid axillary line, at the level of the 4th/5th rib. Insertion of a continuous local anaesthetic infusion catheter(Portex™) and continuation of an infusion of 0.125% levobupivacaine at a rate of 8-12mls/ hour for 48 hours.
Surgically-placed paravertebral block
ACTIVE COMPARATORSurgical placement of paravertebral local anaesthetic infusion catheters (Portex™) prior to closure. Bolus of levobupivacaine as per protocol. Continuation of an infusion of 0.125% levobupivacaine at a rate of 8-12mls/ hour for 48 hours.
Interventions
Deposition of local anaesthetic in the space between the serratus anterior muscle and the external intercostal muscle, at the level of the 4th-5th rib, in the midaxillary line. Procedure performed under ultrasound guidance. Catheter - based infusion of local anaesthetic into this space for 48 hours.
Surgically-placed paravertebral block catheters for continuous local anaesthetic infusion of 0.125% levobupivacaine at 8-12mls/ hr for 48 hours.
Eligibility Criteria
You may qualify if:
- All adults greater than or equal to 18 years of age presenting for minimally-invasive thoracic surgery.
You may not qualify if:
- Patient refusal.
- Local infection at site of insertion.
- Allergy to amide local anaesthetics, opioids, paracetamol, NSAIDs, ketamine, NMBs, volatile anaesthetics.
- Concurrent use of antiarrhythmics with local anaesthetic activity.
- Concurrent use of MAOIs or within 2 weeks of MAOI use.
- Severe renal, liver or cardiac dysfunction.
- Coagulopathy/ anticoagulants that preclude use of PVB/ SAP techniques.
- Inability to comprehend pain scoring system.
- Elderly or frail patients that require a reduction in levobupivacaine dose commensurate with their physical status, resulting in the protocol not being followed.
- Pregnancy, breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mater Misericordiae University Hospital
Dublin, Dublin 7, Ireland
Related Publications (1)
Hanley C, Wall T, Bukowska I, Redmond K, Eaton D, Ni Mhuircheartaigh R, Hearty C. Ultrasound-guided continuous deep serratus anterior plane block versus continuous thoracic paravertebral block for perioperative analgesia in videoscopic-assisted thoracic surgery. Eur J Pain. 2020 Apr;24(4):828-838. doi: 10.1002/ejp.1533. Epub 2020 Jan 30.
PMID: 31955478DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Conor Hearty, FFPMCAI,FFPMANZCA,FCARCSI,FIPP
Consultant Anaesthetist, Mater Misericordiae University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Anaesthetist
Study Record Dates
First Submitted
September 27, 2018
First Posted
December 7, 2018
Study Start
October 4, 2017
Primary Completion
September 1, 2018
Study Completion
September 1, 2018
Last Updated
December 7, 2018
Record last verified: 2018-12